With traceability driven by the Drug Supply Chain Security Act (DSCSA) now flowing across the pharmaceutical supply chain, organizations are beginning to realize the “side-benefits” of interoperable data exchange. Industry leaders will share the progress they’re seeing as well as the challenges still being addressed. While this session offers practical guidance for pharmaceutical companies working to optimize their systems and processes, it also offers attendees from other industries valuable insights into traceability lessons learned and proactive steps to strengthen operations.